If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

29 Jul 2025 17:10

RNS Number : 0649T
Compagnie de Saint-Gobain
29 July 2025
 

SAINT-GOBAIN reinforcES ITS construction chemicals platform WITH three bolt-on ACQUISITIONsin North america, Italy and peru

 

 

Saint-Gobain reinforces its construction chemicals platform with:

 

· Two acquisitions securing key technologies that it will scale across the Group, Interstar Materials in North America and Isoltech in Italy;

 

· A local acquisition in Peru, Soquimic, enhancing Saint-Gobain's footprint in this high-growth market.

 

Interstar Materials is a leading North American manufacturer of high-performance pigments for all segments of concrete including ready-mix and precast concrete. Established in 1987, it operates two facilities in Canada (Quebec and Alberta) and one in the United States (Illinois). Concrete coloring has become popular amongst architects and contractors, with granular pigments having many advantages over liquid or powder pigments: they yield more vibrant colors, are simple to transport and store, easy to handle without temperature constraints and more environmentally friendly. Interstar will enrich Saint-Gobain's range of solutions for the growing demand in decorative concrete solutions for façade, flooring and architectural elements and benefit from the Group's strong presence in construction chemicals in North America.

 

Isoltech is an Italian manufacturer of additives specialized in cellular concrete technology used in the production of lightweight concrete. Established in 1987, it operates a production facility in Verdellino, northern Italy. Its solutions are widely recognized for their excellent thermal and acoustic insulation, as well as their fire resistance, recyclability, vapor and water permeability. Isoltech serves the ready-mix concrete, precast and screed markets.

 

Soquimic is a leading manufacturer of concrete admixtures in Peru. Established in 2013, the company has two plants located in Lurin, near Lima, and in Arequipa, in southern Peru. This transaction will enrich Saint-Gobain's range of solutions and accelerate its growth in Peru, following the acquisition of Z Aditivos in 2021, offering cement additives, and will complement the offering of Weber tile adhesives and facade renders.

 

Interstar, Isoltech and Soquimic generate revenues of around €25 million. They will benefit from Chryso's expertise, innovation and R&D capabilities to support customers in the development of low-carbon materials and from Saint-Gobain's global geographical footprint to expand their portfolio and value proposition in the market.

 

These acquisitions are in line with Saint-Gobain's strategic plan, "Grow & Impact" which aims to both strengthen the Group's worldwide leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Alix Sicaud:

+33 1 88 54 38 70

Yanice Biyogo: 

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRLMFTMTMTBAA
Date   Source Headline
15th Sep 20146:30 pmRNSFinal Terms
5th Sep 20148:01 amRNSJV Saint-Gobain Central Glass in Indonesia
8th Aug 20144:07 pmRNSProspectus supplement
1st Aug 20148:34 amRNSAcquisition
30th Jul 20145:27 pmRNSH1-2014 Results
28th Jul 20147:52 amRNSNew contracts in Qatar
18th Jul 20148:13 amRNSPublication of Prospectus
7th Jul 20145:43 pmRNSAgreement Saint-Gobain / EBRD
2nd Jul 20145:10 pmRNSResult of the 2013 scrip dividend
17th Jun 201410:25 amRNSAcquisition
5th Jun 20146:21 pmRNSAdoption of all resolutions & reappointment of CEO
3rd Jun 20148:15 amRNSJoin Venture
29th Apr 20145:03 pmRNS1st Quarter Results
11th Apr 20144:54 pmRNSDisposal
27th Mar 20149:22 amRNSDecision of the General Court of the EU
4th Mar 20149:19 amRNSProspectus Supplement
19th Feb 20146:08 pmRNSFinal Results
19th Dec 20134:46 pmRNSDisposal
17th Dec 20134:49 pmRNSundrawn bank facilities
4th Dec 20134:50 pmRNSAcquisition
2nd Dec 20134:46 pmRNSSecuritisation programme
28th Nov 20137:00 amRNSFinal Terms
28th Nov 20137:00 amRNSFinal Terms
27th Nov 20136:08 pmRNSInvestor Meeting
25th Nov 20137:00 amRNSFinal Terms
25th Nov 20137:00 amRNSFinal terms
25th Nov 20137:00 amRNSFinal Terms
22nd Nov 20137:00 amRNSDirector renewal
24th Oct 20134:46 pmRNS3rd Quarter Results
30th Sep 20135:53 pmRNSFinal Terms
30th Sep 20137:00 amRNSR&D Center
6th Aug 20137:00 amRNSProspectus supplement
31st Jul 20133:23 pmRNSH1-2013 Financial Report
24th Jul 20135:10 pmRNSHalf Year Results
18th Jul 20138:40 amRNSProspectus
11th Jul 201311:30 amRNSNew plant in Russia
3rd Jul 20134:58 pmRNS2012 dividend
2nd Jul 20138:34 amRNSDisposal
6th Jun 20136:34 pmRNSFinal Terms
6th Jun 20136:25 pmRNSAGM Statement
30th May 20131:28 pmRNSCORRECTIONS TO FINAL TERMS
25th Apr 20135:16 pmRNS1st Quarter Results
9th Apr 20135:11 pmRNSContract in Kuwait
5th Apr 20132:43 pmRNSFinal Terms
5th Apr 20132:43 pmRNSFinal Terms
2nd Apr 201311:08 amRNSDoc Re: Prospectus Supplement
18th Mar 201310:23 amRNSFY 2012 Consolidated Financial Statements
7th Mar 20139:00 amRNSDisposal
6th Mar 20134:48 pmRNSNew plant
21st Feb 20137:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.